Drug Discovery Opinion

We have previously reported on curcumin, the principal active ingredient of turmeric, which has been claimed to have activity against a variety of conditions. Now scientists at Wayne State University have explored the activity of curcumin against cancer stem cells (CSCs).

Colorectal cancer is the third most common form of cancer and, despite aggressive surgical intervention and chemotherapy, almost 50% of patients develop recurrent disease. In epithelial cancers, including colorectal cancer, growing evidence supports the hypothesis that tumour initiation and maintenance is driven by CSCs. Consequently, it is believed that failure to eliminate the underlying CSC population is responsible for cancer recurrence following therapy.

Curcumin has already been shown to have efficacy against a number of tumours in both animal models and early clinical trials. This latest study explored the activity of curcumin on colon cancer derived CSCs, either alone or in combination with the current standard treatment, FOLFOX (5-fluorouracil (5-FU) plus oxaliplatin). In cell culture experiments the researchers demonstrated that FOLFOX treatment increased the percentage of CSCs, presumably due to CSC-sparing. Treatment of these FOLFOX-surviving cells with curcumin alone or in combination with FOLFOX resulted in a marked reduction in the CSC population.

The study, published in Translational Oncology, went on to examine the potential mechanisms for the observed effects. The authors suggest that curcumin may represent a viable adjunct to current chemotherapy of colorectal cancer that could reduce rates of recurrence.

Related posts:

1. Timing Could Be Critical In Chemotherapy The circadian clock regulates a wide range of physiological activities and, for many years, it has been suggested that the...
2. Targeting Breast Cancer Stem Cells Cancer stem cells (CSCs) have been identified in a variety of tumour types, including breast tumours, and have been proposed...
3. High Dose Vitamin C May Reduce Effectiveness of Chemotherapy Vitamin C is an essential nutrient that can be synthesised by most organisms, with humans being the most well-known exception....
4. Salinomycin Selectively Attacks Breast Cancer Stem Cells There is growing evidence for a subpopulation of cells in breast cancer, known as breast cancer stem cells, that may...
5. New Molecular Target for Cancer Treatment The anti-cancer properties of members of the Brassica family have been recognized since the 1970s and one component, indole-3-carbinol, is...

Related posts brought to you by Yet Another Related Posts Plugin.

 Email This Post

This entry was posted on Monday, December 7th, 2009 at 8:48 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.